Opus Genetics, Inc.
IRD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $59,707 | $33,268 | $37,574 |
| - Cash | $30,815 | $32,429 | $41,792 | $30,321 |
| + Debt | $1,068 | $0 | $18,843 | $18,843 |
| Enterprise Value | – | $27,278 | $10,319 | $26,096 |
| Revenue | $3,079 | $2,882 | $4,370 | $4,302 |
| % Growth | 6.8% | -34.1% | 1.6% | – |
| Gross Profit | $3,066 | -$3,140 | $4,370 | -$3,476 |
| % Margin | 99.6% | -109% | 100% | -80.8% |
| EBITDA | -$17,373 | -$8,892 | -$6,809 | -$10,027 |
| % Margin | -564.2% | -308.5% | -155.8% | -233.1% |
| Net Income | -$17,454 | -$7,420 | -$8,194 | -$35,135 |
| % Margin | -566.9% | -257.5% | -187.5% | -816.7% |
| EPS Diluted | -0.25 | -0.12 | -0.24 | -1.11 |
| % Growth | -108.3% | 50% | 78.4% | – |
| Operating Cash Flow | -$6,157 | -$10,269 | -$8,994 | -$7,438 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6,157 | -$10,269 | -$8,994 | -$7,438 |